| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1995;110:302-314
© 1995 Mosby, Inc.
CARDIOPULMONARY BYPASS, |
Winston-Salem, N.C.
Supported in part by grant HL46179 from the National Heart, Lung and Blood Institute of the National Institutes of Health.
Received for publication July 6, 1994. Accepted for publication Nov. 14, 1994. Address for reprints: Jakob Vinten-Johansen, PhD, Department of Cardiothoracic Surgery, Bowman Gray School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157-1096
Abstract
Unenhanced hypothermic cardioplegia does not prevent postischemic endothelial and contractile dysfunction in hearts subjected to antecedent regional or global ischemia. This study tested the hypothesis that supplementing blood cardioplegic solution and reperfusion with the nitric oxide precursor l-arginine would preserve endothelial function, reduce infarct size, and reverse postcardioplegia regional contractile dysfunction by the L-arginine-nitric oxide pathway. In 23 anesthetized dogs, the left anterior descending coronary artery was ligated for 90 minutes, after which total bypass was established for surgical "revascularization." In 10 dogs, unsupplemented multidose hypothermic blood cardioplegic solution was administered for a total of 60 minutes of cardioplegic arrest. In eight dogs, L-arginine was given intravenously (4 mg/kg per minute) and in blood cardioplegic solution (10 mmol) during arrest. In five dogs, the nitric oxide synthesis blocker N
-nitro-L-arginine (1 mmol) was used to block the L-arginine–nitric oxide pathway during cardioplegia and reperfusion. Infarct size (triphenyltetrazolium chloride) as percent of the area at risk was significantly reduced by L-arginine compared with blood cardioplegic solution (28.2% ± 4.1% versus 40.5% ± 3.5%) and was reversed by N-nitro-L-arginine to 68.9% ± 3.0% (p < 0.05). Postischemic regional segmental work in millimeters of mercury per millimeter (sonomicrometry) was significantly better with L-arginine (92 ± 15) versus blood cardioplegic solution (28 ± 3) and N-nitro-L-arginine (26 ± 6). Segmental diastolic stiffness was significantly lower with L-arginine (0.46 ± 0.06) compared with blood cardioplegic solution (1.10 ± 0.11) and was significantly greater with N-nitro-L-arginine (2.70 ± 0.43). In ischemic-reperfused left anterior descending coronary arterial vascular rings, maximum relaxation response to acetylcholine, the stimulator of endothelial nitric oxide, was depressed in the blood cardioplegic solution group (77% ± 4%) and was significantly reversed by L-arginine (92% ± 3%). Smooth muscle function was unaffected in all groups. We conclude that cardioplegic solution supplemented with L-arginine reduces infarct size, preserves postischemic systolic and diastolic regional function, and prevents arterial endothelial dysfunction via the L-arginine–nitric oxide pathway. (J THORACCARDIOVASCSURG1995;110:302-14)
This article has been cited by other articles:
|
|
 |
|
  R. Tepaske, H. te Velthuis, H. M. Oudemans-van Straaten, P. M. M. Bossuyt, M. J. Schultz, L. Eijsman, and M. Vroom Glycine Does Not Add to the Beneficial Effects of Perioperative Oral Immune-Enhancing Nutrition Supplements in High-Risk Cardiac Surgery Patients JPEN J Parenter Enteral Nutr, May 1, 2007; 31(3): 173 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Yang and G.-W. He Effect of Cardioplegic and Organ Preservation Solutions and Their Components on Coronary Endothelium-Derived Relaxing Factors Ann. Thorac. Surg., August 1, 2005; 80(2): 757 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Schulz, M. Kelm, and G. Heusch Nitric oxide in myocardial ischemia/reperfusion injury Cardiovasc Res, February 15, 2004; 61(3): 402 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Nicolini, C. Beghi, C. Muscari, A. Agostinelli, A. M. Budillon, I. Spaggiari, and T. Gherli Myocardial protection in adult cardiac surgery: current options and future challenges Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 986 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Ngaage Off-pump coronary artery bypass grafting: the myth, the logic and the science Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 557 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Szabo, V. Buhmann, T. Andrasi, N. Stumpf, S. Bahrle, V. Kekesi, S. Hagl, C. Szabo, and A. Juhasz-Nagy Poly-ADP-ribose polymerase inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest J. Thorac. Cardiovasc. Surg., September 1, 2003; 126(3): 651 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-Q. Zhao, J. S. Corvera, M. E. Halkos, F. Kerendi, N.-P. Wang, R. A. Guyton, and J. Vinten-Johansen Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol Heart Circ Physiol, August 1, 2003; 285(2): H579 - H588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Ronson, J. D. Puskas, V. H. Thourani, D. A. Velez, B. L. Bufkin, J. Glass, R. A. Guyton, and J. Vinten-Johansen Controlled intermittent asystole cardiac therapy induced by pharmacologically potentiated vagus nerve stimulation in normal and hibernating myocardium Ann. Thorac. Surg., June 1, 2003; 75(6): 1929 - 1936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Brunner, R. Maier, P. Andrew, G. Wolkart, R. Zechner, and B. Mayer Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase Cardiovasc Res, January 1, 2003; 57(1): 55 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Verma, A. Maitland, R. D. Weisel, P. W. M. Fedak, N. C. Pomroy, S.-H. Li, D. A. G. Mickle, R.-K. Li, and V. Rao Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1074 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lass, A. Suessenbacher, G. Wolkart, B. Mayer, and F. Brunner Functional and Analytical Evidence for Scavenging of Oxygen Radicals by L-Arginine Mol. Pharmacol., May 1, 2002; 61(5): 1081 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Carrier, M. Pellerin, L. P. Perrault, D. Bouchard, P. Page, N. Searle, and J. Lavoie Cardioplegic arrest with L-arginine improves myocardial protection: results of a prospective randomized clinical trial Ann. Thorac. Surg., March 1, 2002; 73(3): 837 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Shiono, V. Rao, R. D. Weisel, M. Kawasaki, R.-K. Li, D. A. G. Mickle, P. W. M. Fedak, L. C. Tumiati, L. Ko, and S. Verma L-Arginine protects human heart cells from low-volume anoxia and reoxygenation Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H805 - H815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yan, S. Davani, S. Chocron, B. Kantelip, P. Muret, and J.-P. Kantelip Effects of L-arginine administration before cardioplegic arrest on ischemia-reperfusion injury Ann. Thorac. Surg., December 1, 2001; 72(6): 1985 - 1990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R D Rakhit and M S Marber Nitric oxide: an emerging role in cardioprotection? Heart, October 1, 2001; 86(4): 368 - 372. [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Velez, C. D. Morris, J. M. Budde, S. Muraki, R. N. Otto, R. A. Guyton, and J. Vinten-Johansen All-Blood (Miniplegia) Versus Dilute Cardioplegia in Experimental Surgical Revascularization of Evolving Infarction Circulation, September 18, 2001; 104 (2009): I-296 - I-302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Rossoni, B. Manfredi, V. D. G. Colonna, M. Bernareggi, and F. Berti The Nitroderivative of Aspirin, NCX 4016, Reduces Infarct Size Caused by Myocardial Ischemia-Reperfusion in the Anesthetized Rat J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 380 - 387. [Abstract] [Full Text]
|
|
|
|
|
|
R. D. Riley, H. Sato, Z.-Q. Zhao, V. H. Thourani, J. E. Jordan, A. X. Fernandez, X.-L. Ma, D. R. Hite, D. F. Rigel, T. C. Pellas, et al. Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 350 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zhai, T. E. Eurell, P. S. Cooke, D. B. Lubahn, and D. R. Gross Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1640 - H1647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. H. Thourani, R. S. Ronson, D. G.L. Van Wylen, S. T. Shearer, S. L. Katzmark, Z.-Q. Zhao, D. C. Han, R. A. Guyton, and J. Vinten-Johansen Adenosine-Supplemented Blood Cardioplegia Attenuates Postischemic Dysfunction After Severe Regional Ischemia Circulation, November 9, 1999; 100 (2009): II-376 - II-383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Ronson, V. H. Thourani, X.-L. Ma, S. L. Katzmark, D. Han, Z.-Q. Zhao, M. Nakamura, R. A. Guyton, and J. Vinten-Johansen Peroxynitrite, the Breakdown Product of Nitric Oxide, Is Beneficial in Blood Cardioplegia but Injurious in Crystalloid Cardioplegia Circulation, November 9, 1999; 100 (2009): II-384 - II-391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Kronon, B. S. Allen, A. Halldorsson, S. Rahman, T. Wang, and M. Ilbawi DOSE DEPENDENCY OF L-ARGININE IN NEONATAL MYOCARDIAL PROTECTION: THE NITRIC OXIDE PARADOX J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 655 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Kronon, B. S. Allen, A. Halldorsson, S. Rahman, T. Wang, and M. Ilbawi L-ARGININE, PROSTAGLANDIN, AND WHITE CELL FILTRATION EQUALLY IMPROVE MYOCARDIAL PROTECTION IN STRESSED NEONATAL HEARTS J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 665 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Jordan, Z.-Q. Zhao, and J. Vinten-Johansen The role of neutrophils in myocardial ischemia-reperfusion injury Cardiovasc Res, September 1, 1999; 43(4): 860 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D Rakhit, R. J Edwards, and M. S Marber Nitric oxide, nitrates and ischaemic preconditioning Cardiovasc Res, August 15, 1999; 43(3): 621 - 627. [Full Text] [PDF]
|
|
|
|
 |
|
 H.-S. V. Chen, S. C. Body, and S. K. Shernan Myocardial Preconditioning: Characteristics, Mechanisms, and Clinical Applications Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1999; 3(2): 85 - 97. [Abstract] [PDF]
|
|
|
|
 |
|
 G. I. Gorodeski, M. N. Levy, T. Yang, J. Goldfarb, and W. H. Utian Beneficial Effects of Estrogen on Cardiac Stunning in Female Rabbits Reproductive Sciences, March 1, 1999; 6(2): 80 - 87. [Abstract] [PDF]
|
|
|
|
|
|
G.-L. Liu, T. A. Christopher, B. L. Lopez, F. Gao, Y. Guo, E. Gao, K. Knuettel, M. Feelisch, and X. L. Ma SP/W-5186, A Cysteine-Containing Nitric Oxide Donor, Attenuates Postischemic Myocardial Injury J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 527 - 537. [Abstract] [Full Text]
|
|
|
|
|
|
B. L. Bufkin, S. T. Shearer, J. Vinten-Johansen, I. G. Duarte, V. H. Thourani, M. Nakamura, Z.-Q. Zhao, and R. A. Guyton Preconditioning during simulated MIDCABG attenuates blood flow defects and neutrophil accumulation Ann. Thorac. Surg., September 1, 1998; 66(3): 726 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Carrier, M. Pellerin, P. L. Page, N. R. Searle, R. Martineau, C. Caron, B. C. Solymoss, and L. C. Pelletier Can L-arginine improve myocardial protection during cardioplegic arrest? Results of a phase I pilot study Ann. Thorac. Surg., July 1, 1998; 66(1): 108 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. G. Duarte, S. T. Shearer, M. J. MacDonald, J. P. Gott, W. M. Brown III, J. Vinten-Johansen, and R. A. Guyton Myocardial Distribution of Antegrade Cold Crystalloid and Tepid Blood Cardioplegia Ann. Thorac. Surg., June 1, 1998; 65(6): 1610 - 1616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mizuno, M. Watanabe, T. Sakamoto, and M. Sunamori L-Arginine, a nitric oxide precursor, attenuates ischemia-reperfusion injury by inhibiting inositol-1,4,5-triphosphate J. Thorac. Cardiovasc. Surg., April 1, 1998; 115(4): 931 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Steingrub Novel Insights Into the Pathogenesis and Therapy of Circulatory Shock Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1998; 2(1): 31 - 45. [Abstract] [PDF]
|
|
|
|
|
|
L. Fei, A. D. Baron, D. P. Henry, and D. P. Zipes Intrapericardial Delivery of L-Arginine Reduces the Increased Severity of Ventricular Arrhythmias During Sympathetic Stimulation in Dogs With Acute Coronary Occlusion : Nitric Oxide Modulates Sympathetic Effects on Ventricular Electrophysiological Properties Circulation, December 2, 1997; 96(11): 4044 - 4049. [Abstract] [Full Text]
|
|
|
|
|
|
G. Champsaur, C. Vedrinne, S. Martinot, F. Tronc, J. Robin, J. Ninet, and M. Franck FLOW-INDUCED RELEASE OF ENDOTHELIUM-DERIVED RELAXING FACTOR DURING PULSATILE BYPASS: EXPERIMENTAL STUDY IN THE FETAL LAMB J. Thorac. Cardiovasc. Surg., November 1, 1997; 114(5): 738 - 745. [Abstract] [Full Text]
|
|
|
|
|
|
X. L Ma, B. L Lopez, G.-L. Liu, T. A Christopher, and H. Ischiropoulos Peroxynitrite aggravates myocardial reperfusion injury in the isolated perfused rat heart Cardiovasc Res, November 1, 1997; 36(2): 195 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-W. He and C.-Q. Yang SUPERIORITY OF HYPERPOLARIZING TO DEPOLARIZING CARDIOPLEGIA IN PROTECTION OF CORONARY ENDOTHELIAL FUNCTION J. Thorac. Cardiovasc. Surg., October 1, 1997; 114(4): 643 - 650. [Abstract] [Full Text]
|
|
|
|
|
|
M. S. Bhabra, D. N. Hopkinson, T. E. Shaw, and T. L. Hooper ATTENUATION OF LUNG GRAFT REPERFUSION INJURY BY A NITRIC OXIDE DONOR J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 327 - 334. [Abstract] [Full Text]
|
|
|
|
|
|
H. Sato, Z.-Q. Zhao, J. E. Jordan, J. C. Todd, R. D. Riley, C. S. Taft, J. W. Hammon Jr., P. Li, X.-l. Ma, and J. Vinten-Johansen BASAL NITRIC OXIDE EXPRESSES ENDOGENOUS CARDIOPROTECTION DURING REPERFUSION BY INHIBITION OF NEUTROPHIL-MEDIATED DAMAGE AFTER SURGICAL REVASCULARIZATION J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 399 - 409. [Abstract] [Full Text]
|
|
|
|
|
|
G.-W. He Hyperkalemia Exposure Impairs EDHF-Mediated Endothelial Function in the Human Coronary Artery Ann. Thorac. Surg., January 1, 1997; 63(1): 84 - 87. [Abstract] [Full Text]
|
|
|
|
|
|
J. E. Jordan, Z.-Q. Zhao, H. Sato, S. Taft, and J. Vinten-Johansen Adenosine A2 Receptor Activation Attenuates Reperfusion Injury by Inhibiting Neutrophil Accumulation, Superoxide Generation and Coronary Endothelial Adherence J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 301 - 309. [Abstract] [Full Text]
|
|
|
|
|
|
G.-W. He and C.-Q. Yang Hyperkalemia Alters Endothelium-Dependent Relaxation Through Non-Nitric Oxide and Noncyclooxygenase Pathway: A Mechanism for Coronary Dysfunction due to Cardioplegia Ann. Thorac. Surg., May 1, 1996; 61(5): 1394 - 1399. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
